France has submitted an intention to restrict the placing on the market and reuse of treated articles with creosote or creosote-related substances.
Only representatives must identify the non-EU manufacturers they represent and provide their contact information in REACH-IT by 14 October 2022.
ECHA has published a report assessing the regulatory needs for a group of hydroxyacid amides.
ECHA’s Member State Committee (MSC) agreed to modify the approach for investigating chromosomal aberration under REACH dossier evaluation.
A new authorisation for the use of one substance has been granted.
REACH Study Results has been refreshed, with 654 new substances added since September 2021.